In 1991, Dr. Frank Mathias, a freshly graduated French pharmacist of the Paris VI University, entered the German pharmaceutical industry, the largest at the time. Since then, he was able to experience different corporate and leadership cultures in multiple management positions: from then global giant Hoechst AG, via family-owned French Servier, followed by American top Biotech Amgen, to publicly listed German Medigene AG — leading him to Rentschler Biopharma SE as CEO in 2016. As Chairman of vfa bio, he is representing German biotech industry interests. Frank champions long-term strategic growth in the biopharmaceutical industry.
.svg)
